NEW YORK  (GenomeWeb News) — Ingenuity Systems today said that Wyeth Pharmaceuticals has extended and expanded a licensing agreement for its Pathway Analysis software.
 
Wyeth’s researchers will use the IPA software to study pharmacogenomic biomarkers and other areas, Ingenuity said.
 
Ingenuity said Wyeth has been using its software since 2003.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.